Correlation Between Amylyx Pharmaceuticals and AbbVie

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Amylyx Pharmaceuticals and AbbVie at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amylyx Pharmaceuticals and AbbVie into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amylyx Pharmaceuticals and AbbVie Inc, you can compare the effects of market volatilities on Amylyx Pharmaceuticals and AbbVie and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amylyx Pharmaceuticals with a short position of AbbVie. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amylyx Pharmaceuticals and AbbVie.

Diversification Opportunities for Amylyx Pharmaceuticals and AbbVie

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Amylyx and AbbVie is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Amylyx Pharmaceuticals and AbbVie Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AbbVie Inc and Amylyx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amylyx Pharmaceuticals are associated (or correlated) with AbbVie. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AbbVie Inc has no effect on the direction of Amylyx Pharmaceuticals i.e., Amylyx Pharmaceuticals and AbbVie go up and down completely randomly.

Pair Corralation between Amylyx Pharmaceuticals and AbbVie

Given the investment horizon of 90 days Amylyx Pharmaceuticals is expected to generate 1.79 times more return on investment than AbbVie. However, Amylyx Pharmaceuticals is 1.79 times more volatile than AbbVie Inc. It trades about 0.08 of its potential returns per unit of risk. AbbVie Inc is currently generating about -0.08 per unit of risk. If you would invest  533.00  in Amylyx Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of  33.00  from holding Amylyx Pharmaceuticals or generate 6.19% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Amylyx Pharmaceuticals  vs.  AbbVie Inc

 Performance 
       Timeline  
Amylyx Pharmaceuticals 

Risk-Adjusted Performance

23 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Amylyx Pharmaceuticals are ranked lower than 23 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating essential indicators, Amylyx Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
AbbVie Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AbbVie Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's fundamental drivers remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Amylyx Pharmaceuticals and AbbVie Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Amylyx Pharmaceuticals and AbbVie

The main advantage of trading using opposite Amylyx Pharmaceuticals and AbbVie positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amylyx Pharmaceuticals position performs unexpectedly, AbbVie can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AbbVie will offset losses from the drop in AbbVie's long position.
The idea behind Amylyx Pharmaceuticals and AbbVie Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account